中国胸心血管外科临床杂志

中国胸心血管外科临床杂志

终末期肝病/肝移植术后合并冠心病患者不停跳冠状动脉旁路移植术三例

查看全文

关键词: 终末期肝病; 肝移植术后; 不停跳冠状动脉旁路移植术

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Brennan DC. Long-term trends in allograft survival. Adv Chronic Kidney Dis, 2006, 13(1): 11-17.
2. Agrawal A, Jain D, Dias A, et al. Real World Utility of Dobutamine Stress echocardiography in Predicting Perioperative Cardiovascular Morbidity and Mortality after Orthotopic Liver Transplantation. Korean Circ J, 2018, 48(9): 828-835.
3. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant, 2002, 2(9): 807-818.
4. Jaruvongvanich V, Wirunsawanya K, Sanguankeo A, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta -analysis. Dig Liver Dis, 2016, 48(12): 140-1417.
5. Alyan O, Kacmaz F, Ozdemir O, et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J, 2008, 72(12): 1960-1965.
6. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol, 2006, 98(2): 178-181.
7. Kalaitzakis E, Rosengren A, Skommevik T, et al. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci, 2010, 55(2): 467-475.
8. Kalaitzakis E, Rosengren A, Skommevik T, et al. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci, 2010, 55(2): 467-475.
9. Patel SS, Nabi E, Guzman L, et al. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transpl, 2018, 24(3): 333-342.
10. Arslan U, Turkoglu S, Balcioglu S, et al. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis, 2007, 18(6): 433-436.
11. Agaç M T, Korkmaz L, Cavusoglu G, et al. Association between nonalcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: a pilot study. Angiology, 2013, 64(8): 604-608.
12. Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post liver transplant: results of the niddk long term follow-up study. Am J Transplant, 2010, 10(6): 1420-1427.
13. Arslan U, Kocaoğlu I, Balcı M, et al. The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease. J Cardiol, 2012, 60(3): 210-214.
14. Siddiqui M S, Fuchs M, Idowu M O, et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis associate with atherogenic lipoprotein profile. Clin Gastroenterol Hepatol, 2015, 13(5): 1000-1008.e3.
15. Hsieh MJ, Chen CC, Lee TH, et al. Metabolic syndrome and homocysteine level as predictors of the severity of coronary artery disease in patients with carotid stenosis. Am J Med Sci, 2009, 338(6): 447-452.
16. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med, 2004, 351(25): 2599-2610.
17. Members WC, Hillis LD, Smith PK, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary. J Thorac Cardiovasc Surg, 2012, 143(1): 4-34.
18. Klemperer JD, Ko W, Krieger KH, et al. Cardiac operations in patients with cirrhosis. Ann Thorac Surg, 1998, 65(1): 85-87.
19. Bizouarn P, Ausseur A, Desseigne P, et al. Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann Thorac Surg, 1999, 67(5): 1334-1338.